Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomass Resin Holdings is a Japanese biotechnology and manufacturing company specializing in the development of sustainable bioplastics derived from non-edible rice. The company's flagship product, Rice Resin, utilizes upcycled rice waste and rice that is unfit for consumption to create biodegradable and durable plastic alternatives. By integrating agricultural waste into the industrial supply chain, the company aims to reduce carbon emissions and plastic pollution while supporting local farming communities. Biomass Resin Holdings operates several manufacturing facilities across Japan and is expanding its global footprint through strategic partnerships in Southeast Asia and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMASS.